Skip to main content
Top
Published in: Respiratory Research 1/2022

Open Access 01-12-2022 | Smoking and Nicotine Detoxification | Research

Effects of repeated infections with non-typeable Haemophilus influenzae on lung in vitamin D deficient and smoking mice

Authors: Jef Serré, Ajime Tom Tanjeko, Carolien Mathyssen, Tobias Heigl, Annelore Sacreas, Dana Paulina Cook, Erik Verbeken, Karen Maes, Jan Verhaegen, Charles Pilette, Jeroen Vanoirbeek, Conny Gysemans, Chantal Mathieu, Bart Vanaudenaerde, Wim Janssens, Ghislaine Gayan-Ramirez

Published in: Respiratory Research | Issue 1/2022

Login to get access

Abstract

Background

In chronic obstructive pulmonary disease (COPD), exacerbations cause acute inflammatory flare-ups and increase the risk for hospitalization and mortality. Exacerbations are common in all disease stages and are often caused by bacterial infections e.g., non-typeable Heamophilus influenzae (NTHi). Accumulating evidence also associates vitamin D deficiency with the severity of COPD and exacerbation frequency. However, it is still unclear whether vitamin D deficiency when combined with cigarette smoking would worsen and prolong exacerbations caused by repeated infections with the same bacterial strain.

Methods

Vitamin D sufficient (VDS) and deficient (VDD) mice were exposed to nose-only cigarette smoke (CS) for 14 weeks and oropharyngeally instilled with NTHi at week 6, 10 and 14. Three days after the last instillation, mice were assessed for lung function, tissue remodeling, inflammation and immunity. The impact of VDD and CS on inflammatory cells and immunoglobulin (Ig) production was also assessed in non-infected animals while serum Ig production against NTHi and dsDNA was measured in COPD patients before and 1 year after supplementation with Vitamin D3.

Results

VDD enhanced NTHi eradication, independently of CS and complete eradication was reflected by decreased anti-NTHi Ig’s within the lung. In addition, VDD led to an increase in total lung capacity (TLC), lung compliance (Cchord), MMP12/TIMP1 ratio with a rise in serum Ig titers and anti-dsDNA Ig’s. Interestingly, in non-infected animals, VDD exacerbated the CS-induced anti-NTHi Ig’s, anti-dsDNA Ig’s and inflammatory cells within the lung. In COPD patients, serum Ig production was not affected by vitamin D status but anti-NTHi IgG increased after vitamin D3 supplementation in patients who were Vitamin D insufficient before treatment.

Conclusion

During repeated infections, VDD facilitated NTHi eradication and resolution of local lung inflammation through production of anti-NTHi Ig, independently of CS whilst it also promoted autoantibodies. In COPD patients, vitamin D supplementation could be protective against NTHi infections in vitamin D insufficient patients. Future research is needed to decipher the determinants of dual effects of VDD on adaptive immunity.

Trail registration

ClinicalTrials, NCT00666367. Registered 23 April 2008, https://​www.​clinicaltrials.​gov/​ct2/​show/​study/​NCT00666367.
Appendix
Available only for authorised users
Literature
4.
go back to reference Heulens N, Korf H, Mathyssen C, Everaerts S, De Smidt E, Dooms C, et al. 1,25-Dihydroxyvitamin D modulates antibacterial and inflammatory response in human cigarette smoke-exposed macrophages. PLoS ONE. 2016;11:e0160482.PubMedPubMedCentralCrossRef Heulens N, Korf H, Mathyssen C, Everaerts S, De Smidt E, Dooms C, et al. 1,25-Dihydroxyvitamin D modulates antibacterial and inflammatory response in human cigarette smoke-exposed macrophages. PLoS ONE. 2016;11:e0160482.PubMedPubMedCentralCrossRef
5.
go back to reference Subramaniam R, Mukherjee S, Chen H, Keshava S, Neuenschwander P, Shams H. Restoring cigarette smoke-induced impairment of efferocytosis in alveolar macrophages. Mucosal Immunol. 2016;9:873–83.PubMedCrossRef Subramaniam R, Mukherjee S, Chen H, Keshava S, Neuenschwander P, Shams H. Restoring cigarette smoke-induced impairment of efferocytosis in alveolar macrophages. Mucosal Immunol. 2016;9:873–83.PubMedCrossRef
6.
go back to reference Hurst JR, Vestbo J, Anzueto A, Locantore N, Müllerova H, Tal-Singer R, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363:1128–38.PubMedCrossRef Hurst JR, Vestbo J, Anzueto A, Locantore N, Müllerova H, Tal-Singer R, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363:1128–38.PubMedCrossRef
7.
8.
go back to reference Janssens W, Bouillon R, Claes B, Carremans C, Lehouck A, Buysschaert I, et al. Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene. Thorax. 2010;65:215–20.PubMedCrossRef Janssens W, Bouillon R, Claes B, Carremans C, Lehouck A, Buysschaert I, et al. Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene. Thorax. 2010;65:215–20.PubMedCrossRef
9.
go back to reference Jolliffe DA, Greenberg L, Hooper RL, Mathyssen C, Rafiq R, de Jongh RT, et al. Vitamin D to prevent exacerbations of COPD: systematic review and meta-analysis of individual participant data from randomised controlled trials. Thorax. 2019 Jolliffe DA, Greenberg L, Hooper RL, Mathyssen C, Rafiq R, de Jongh RT, et al. Vitamin D to prevent exacerbations of COPD: systematic review and meta-analysis of individual participant data from randomised controlled trials. Thorax. 2019
10.
go back to reference Lehouck A, Mathieu C, Carremans C, Baeke F, Verhaegen J, Van Eldere J, et al. High doses of vitamin D to reduce exacerbations in chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med. 2012;156:105–14.PubMedCrossRef Lehouck A, Mathieu C, Carremans C, Baeke F, Verhaegen J, Van Eldere J, et al. High doses of vitamin D to reduce exacerbations in chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med. 2012;156:105–14.PubMedCrossRef
13.
go back to reference Gregori S, Giarratana N, Smiroldo S, Uskokovic M, Adorini L. A 1alpha,25-dihydroxyvitamin D(3) analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice. Diabetes. 2002;51:1367–74.PubMedCrossRef Gregori S, Giarratana N, Smiroldo S, Uskokovic M, Adorini L. A 1alpha,25-dihydroxyvitamin D(3) analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice. Diabetes. 2002;51:1367–74.PubMedCrossRef
14.
go back to reference Vanherwegen A-S, Cook DP, Ferreira GB, Gysemans C, Mathieu C. Vitamin D-modulated dendritic cells delay lethal graft-versus-host disease through induction of regulatory T cells. J Steroid Biochem Mol Biol. 2019;188:103–10.PubMedCrossRef Vanherwegen A-S, Cook DP, Ferreira GB, Gysemans C, Mathieu C. Vitamin D-modulated dendritic cells delay lethal graft-versus-host disease through induction of regulatory T cells. J Steroid Biochem Mol Biol. 2019;188:103–10.PubMedCrossRef
15.
go back to reference Vanherwegen A-S, Eelen G, Ferreira GB, Ghesquière B, Cook DP, Nikolic T, et al. Vitamin D controls the capacity of human dendritic cells to induce functional regulatory T cells by regulation of glucose metabolism. J Steroid Biochem Mol Biol. 2019;187:134–45.PubMedCrossRef Vanherwegen A-S, Eelen G, Ferreira GB, Ghesquière B, Cook DP, Nikolic T, et al. Vitamin D controls the capacity of human dendritic cells to induce functional regulatory T cells by regulation of glucose metabolism. J Steroid Biochem Mol Biol. 2019;187:134–45.PubMedCrossRef
17.
go back to reference Chen H, Lu R, Zhang Y-G, Sun J. Vitamin D receptor deletion leads to the destruction of tight and adherens junctions in lungs. Tissue Barriers. 2018;6:1–13.PubMedPubMedCentralCrossRef Chen H, Lu R, Zhang Y-G, Sun J. Vitamin D receptor deletion leads to the destruction of tight and adherens junctions in lungs. Tissue Barriers. 2018;6:1–13.PubMedPubMedCentralCrossRef
18.
go back to reference Sundar IK, Hwang J-W, Wu S, Sun J, Rahman I. Deletion of vitamin D receptor leads to premature emphysema/COPD by increased matrix metalloproteinases and lymphoid aggregates formation. Biochem Biophys Res Commun. 2011;406:127–33.PubMedPubMedCentralCrossRef Sundar IK, Hwang J-W, Wu S, Sun J, Rahman I. Deletion of vitamin D receptor leads to premature emphysema/COPD by increased matrix metalloproteinases and lymphoid aggregates formation. Biochem Biophys Res Commun. 2011;406:127–33.PubMedPubMedCentralCrossRef
19.
go back to reference Heulens N, Korf H, Cielen N, De Smidt E, Maes K, Gysemans C, et al. Vitamin D deficiency exacerbates COPD-like characteristics in the lungs of cigarette smoke-exposed mice. Respir Res. 2015;16:110.PubMedPubMedCentralCrossRef Heulens N, Korf H, Cielen N, De Smidt E, Maes K, Gysemans C, et al. Vitamin D deficiency exacerbates COPD-like characteristics in the lungs of cigarette smoke-exposed mice. Respir Res. 2015;16:110.PubMedPubMedCentralCrossRef
20.
go back to reference Palacios C, Gonzalez L. Is vitamin D deficiency a major global public health problem? J Steroid Biochem Mol Biol. 2014;144:138–45.PubMedCrossRef Palacios C, Gonzalez L. Is vitamin D deficiency a major global public health problem? J Steroid Biochem Mol Biol. 2014;144:138–45.PubMedCrossRef
21.
go back to reference Oosterwerff MM, Eekhoff EMW, Heymans MW, Lips P, van Schoor NM. Serum 25-hydroxyvitamin D levels and the metabolic syndrome in older persons: a population-based study. Clin Endocrinol (Oxf). 2011;75:608–13.CrossRef Oosterwerff MM, Eekhoff EMW, Heymans MW, Lips P, van Schoor NM. Serum 25-hydroxyvitamin D levels and the metabolic syndrome in older persons: a population-based study. Clin Endocrinol (Oxf). 2011;75:608–13.CrossRef
22.
go back to reference Ginde AA, Mansbach JM, Camargo CA. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch Intern Med. 2009;169:384–90.PubMedPubMedCentralCrossRef Ginde AA, Mansbach JM, Camargo CA. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch Intern Med. 2009;169:384–90.PubMedPubMedCentralCrossRef
23.
go back to reference Jat KR. Vitamin D deficiency and lower respiratory tract infections in children: a systematic review and meta-analysis of observational studies. Trop Doct. 2017;47:77–84.PubMedCrossRef Jat KR. Vitamin D deficiency and lower respiratory tract infections in children: a systematic review and meta-analysis of observational studies. Trop Doct. 2017;47:77–84.PubMedCrossRef
24.
go back to reference Quraishi SA, Bittner EA, Christopher KB, Camargo CA. Vitamin D status and community-acquired pneumonia: results from the third National Health and Nutrition Examination Survey. PLoS ONE. 2013;8:e81120.PubMedPubMedCentralCrossRef Quraishi SA, Bittner EA, Christopher KB, Camargo CA. Vitamin D status and community-acquired pneumonia: results from the third National Health and Nutrition Examination Survey. PLoS ONE. 2013;8:e81120.PubMedPubMedCentralCrossRef
25.
go back to reference Huang S-J, Wang X-H, Liu Z-D, Cao W-L, Han Y, Ma A-G, et al. Vitamin D deficiency and the risk of tuberculosis: a meta-analysis. Drug Des Dev Ther. 2017;11:91–102.CrossRef Huang S-J, Wang X-H, Liu Z-D, Cao W-L, Han Y, Ma A-G, et al. Vitamin D deficiency and the risk of tuberculosis: a meta-analysis. Drug Des Dev Ther. 2017;11:91–102.CrossRef
26.
go back to reference Islam S, Sarkar NK, Mujahid AA, Bennoor KS, Hossain SS, Attar MM, et al. Association of serum vitamin D (25OHD) level with acute exacerbation of chronic obstructive pulmonary disease. Mymensingh Med J MMJ. 2019;28:441–8.PubMed Islam S, Sarkar NK, Mujahid AA, Bennoor KS, Hossain SS, Attar MM, et al. Association of serum vitamin D (25OHD) level with acute exacerbation of chronic obstructive pulmonary disease. Mymensingh Med J MMJ. 2019;28:441–8.PubMed
27.
go back to reference Malinovschi A, Masoero M, Bellocchia M, Ciuffreda A, Solidoro P, Mattei A, et al. Severe vitamin D deficiency is associated with frequent exacerbations and hospitalization in COPD patients. Respir Res. 2014;15:131.PubMedPubMedCentralCrossRef Malinovschi A, Masoero M, Bellocchia M, Ciuffreda A, Solidoro P, Mattei A, et al. Severe vitamin D deficiency is associated with frequent exacerbations and hospitalization in COPD patients. Respir Res. 2014;15:131.PubMedPubMedCentralCrossRef
28.
go back to reference Shi Y-Y, Liu T-J, Fu J-H, Xu W, Wu L-L, Hou A-N, et al. Vitamin D/VDR signaling attenuates lipopolysaccharide-induced acute lung injury by maintaining the integrity of the pulmonary epithelial barrier. Mol Med Rep. 2016;13:1186–94.PubMedCrossRef Shi Y-Y, Liu T-J, Fu J-H, Xu W, Wu L-L, Hou A-N, et al. Vitamin D/VDR signaling attenuates lipopolysaccharide-induced acute lung injury by maintaining the integrity of the pulmonary epithelial barrier. Mol Med Rep. 2016;13:1186–94.PubMedCrossRef
29.
go back to reference Li P, Xu X, Cao E, Yu B, Li W, Fan M, et al. Vitamin D deficiency causes defective resistance to Aspergillus fumigatus in mice via aggravated and sustained inflammation. PLoS ONE. 2014;9:e99805.PubMedPubMedCentralCrossRef Li P, Xu X, Cao E, Yu B, Li W, Fan M, et al. Vitamin D deficiency causes defective resistance to Aspergillus fumigatus in mice via aggravated and sustained inflammation. PLoS ONE. 2014;9:e99805.PubMedPubMedCentralCrossRef
30.
go back to reference Niederstrasser J, Herr C, Wolf L, Lehr CM, Beisswenger C, Bals R. Vitamin D deficiency does not result in a breach of host defense in murine models of pneumonia. Infect Immun. 2016;84:3097–104.PubMedPubMedCentralCrossRef Niederstrasser J, Herr C, Wolf L, Lehr CM, Beisswenger C, Bals R. Vitamin D deficiency does not result in a breach of host defense in murine models of pneumonia. Infect Immun. 2016;84:3097–104.PubMedPubMedCentralCrossRef
31.
go back to reference Herr C, Han G, Li D, Tschernig T, Dinh QT, Beißwenger C, et al. Combined exposure to bacteria and cigarette smoke resembles characteristic phenotypes of human COPD in a murine disease model. Exp Toxicol Pathol. 2015;67:261–9.PubMedCrossRef Herr C, Han G, Li D, Tschernig T, Dinh QT, Beißwenger C, et al. Combined exposure to bacteria and cigarette smoke resembles characteristic phenotypes of human COPD in a murine disease model. Exp Toxicol Pathol. 2015;67:261–9.PubMedCrossRef
32.
go back to reference Serré J, Mathyssen C, Ajime TT, Korf H, Maes K, Heulens N, et al. Airway infection with nontypeable Haemophilus influenzae is more rapidly eradicated in vitamin D deficient mice. J Steroid Biochem Mol Biol. 2019;187:42–51.PubMedCrossRef Serré J, Mathyssen C, Ajime TT, Korf H, Maes K, Heulens N, et al. Airway infection with nontypeable Haemophilus influenzae is more rapidly eradicated in vitamin D deficient mice. J Steroid Biochem Mol Biol. 2019;187:42–51.PubMedCrossRef
33.
go back to reference Vanoirbeek JAJ, Rinaldi M, De Vooght V, Haenen S, Bobic S, Gayan-Ramirez G, et al. Noninvasive and invasive pulmonary function in mouse models of obstructive and restrictive respiratory diseases. Am J Respir Cell Mol Biol. 2010;42:96–104.PubMedCrossRef Vanoirbeek JAJ, Rinaldi M, De Vooght V, Haenen S, Bobic S, Gayan-Ramirez G, et al. Noninvasive and invasive pulmonary function in mouse models of obstructive and restrictive respiratory diseases. Am J Respir Cell Mol Biol. 2010;42:96–104.PubMedCrossRef
34.
go back to reference Sze MA, Dimitriu PA, Suzuki M, McDonough JE, Campbell JD, Brothers JF, et al. Host response to the lung microbiome in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2015;192:438–45.PubMedPubMedCentralCrossRef Sze MA, Dimitriu PA, Suzuki M, McDonough JE, Campbell JD, Brothers JF, et al. Host response to the lung microbiome in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2015;192:438–45.PubMedPubMedCentralCrossRef
35.
go back to reference Ubags NDJ, Marsland BJ. Mechanistic insight into the function of the microbiome in lung diseases. Eur Respir J. 2017;50:3.CrossRef Ubags NDJ, Marsland BJ. Mechanistic insight into the function of the microbiome in lung diseases. Eur Respir J. 2017;50:3.CrossRef
36.
go back to reference Su Y-C, Jalalvand F, Thegerström J, Riesbeck K. The interplay between immune response and bacterial infection in COPD: focus upon non-typeable Haemophilus influenzae. Front Immunol. 2018;9:2530.PubMedPubMedCentralCrossRef Su Y-C, Jalalvand F, Thegerström J, Riesbeck K. The interplay between immune response and bacterial infection in COPD: focus upon non-typeable Haemophilus influenzae. Front Immunol. 2018;9:2530.PubMedPubMedCentralCrossRef
37.
go back to reference Lacoma A, Edwards AM, Young BC, Domínguez J, Prat C, Laabei M. Cigarette smoke exposure redirects Staphylococcus aureus to a virulence profile associated with persistent infection. Sci Rep. 2019;9:10798.PubMedPubMedCentralCrossRef Lacoma A, Edwards AM, Young BC, Domínguez J, Prat C, Laabei M. Cigarette smoke exposure redirects Staphylococcus aureus to a virulence profile associated with persistent infection. Sci Rep. 2019;9:10798.PubMedPubMedCentralCrossRef
38.
go back to reference Sethi S. Bacteria in exacerbations of chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2004;1:109–14.PubMedCrossRef Sethi S. Bacteria in exacerbations of chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2004;1:109–14.PubMedCrossRef
40.
go back to reference Christensen PJ, Preston AM, Ling T, Du M, Fields WB, Curtis JL, et al. Pneumocystis murina infection and cigarette smoke exposure interact to cause increased organism burden, development of airspace enlargement, and pulmonary inflammation in mice. Infect Immun. 2008;76:3481–90.PubMedPubMedCentralCrossRef Christensen PJ, Preston AM, Ling T, Du M, Fields WB, Curtis JL, et al. Pneumocystis murina infection and cigarette smoke exposure interact to cause increased organism burden, development of airspace enlargement, and pulmonary inflammation in mice. Infect Immun. 2008;76:3481–90.PubMedPubMedCentralCrossRef
41.
go back to reference Voss M, Wonnenberg B, Honecker A, Kamyschnikow A, Herr C, Bischoff M, et al. Cigarette smoke-promoted acquisition of bacterial pathogens in the upper respiratory tract leads to enhanced inflammation in mice. Respir Res. 2015;16:41.PubMedPubMedCentralCrossRef Voss M, Wonnenberg B, Honecker A, Kamyschnikow A, Herr C, Bischoff M, et al. Cigarette smoke-promoted acquisition of bacterial pathogens in the upper respiratory tract leads to enhanced inflammation in mice. Respir Res. 2015;16:41.PubMedPubMedCentralCrossRef
42.
go back to reference Gou X, Zhang Q, More S, Bamunuarachchi G, Liang Y, Khan FH, et al. Repeated exposure to Streptococcus pneumoniae exacerbates chronic obstructive pulmonary disease. Am J Pathol. 2019;189(9):1711–20.PubMedPubMedCentralCrossRef Gou X, Zhang Q, More S, Bamunuarachchi G, Liang Y, Khan FH, et al. Repeated exposure to Streptococcus pneumoniae exacerbates chronic obstructive pulmonary disease. Am J Pathol. 2019;189(9):1711–20.PubMedPubMedCentralCrossRef
43.
go back to reference Ganesan S, Comstock AT, Kinker B, Mancuso P, Beck JM, Sajjan US. Combined exposure to cigarette smoke and nontypeable Haemophilus influenzae drives development of a COPD phenotype in mice. Respir Res. 2014;15:11.PubMedPubMedCentralCrossRef Ganesan S, Comstock AT, Kinker B, Mancuso P, Beck JM, Sajjan US. Combined exposure to cigarette smoke and nontypeable Haemophilus influenzae drives development of a COPD phenotype in mice. Respir Res. 2014;15:11.PubMedPubMedCentralCrossRef
44.
go back to reference Tejero JD, Armand NC, Finn CM, Dhume K, Strutt TM, Chai KX, et al. Cigarette smoke extract acts directly on CD4 T cells to enhance Th1 polarization and reduce memory potential. Cell Immunol. 2018;331:121–9.PubMedPubMedCentralCrossRef Tejero JD, Armand NC, Finn CM, Dhume K, Strutt TM, Chai KX, et al. Cigarette smoke extract acts directly on CD4 T cells to enhance Th1 polarization and reduce memory potential. Cell Immunol. 2018;331:121–9.PubMedPubMedCentralCrossRef
45.
go back to reference Shang S, Ordway D, Henao-Tamayo M, Bai X, Oberley-Deegan R, Shanley C, et al. Cigarette smoke increases susceptibility to tuberculosis–evidence from in vivo and in vitro models. J Infect Dis. 2011;203:1240–8.PubMedCrossRef Shang S, Ordway D, Henao-Tamayo M, Bai X, Oberley-Deegan R, Shanley C, et al. Cigarette smoke increases susceptibility to tuberculosis–evidence from in vivo and in vitro models. J Infect Dis. 2011;203:1240–8.PubMedCrossRef
46.
go back to reference Yuzefpolskiy Y, Baumann FM, Penny LA, Studzinski GP, Kalia V, Sarkar S. Vitamin D receptor signals regulate effector and memory CD8 T cell responses to infections in mice. J Nutr. 2014;144:2073–82.PubMedCrossRef Yuzefpolskiy Y, Baumann FM, Penny LA, Studzinski GP, Kalia V, Sarkar S. Vitamin D receptor signals regulate effector and memory CD8 T cell responses to infections in mice. J Nutr. 2014;144:2073–82.PubMedCrossRef
47.
go back to reference Chung KF, Adcock IM. Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction. Eur Respir J. 2008;31:1334–56.PubMedCrossRef Chung KF, Adcock IM. Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction. Eur Respir J. 2008;31:1334–56.PubMedCrossRef
48.
go back to reference Bhat TA, Panzica L, Kalathil SG, Thanavala Y. Immune dysfunction in patients with chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2015;12(Suppl 2):S169-175.PubMedPubMedCentralCrossRef Bhat TA, Panzica L, Kalathil SG, Thanavala Y. Immune dysfunction in patients with chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2015;12(Suppl 2):S169-175.PubMedPubMedCentralCrossRef
49.
go back to reference Hasday JD, Bascom R, Costa JJ, Fitzgerald T, Dubin W. Bacterial endotoxin is an active component of cigarette smoke. Chest. 1999;115:829–35.PubMedCrossRef Hasday JD, Bascom R, Costa JJ, Fitzgerald T, Dubin W. Bacterial endotoxin is an active component of cigarette smoke. Chest. 1999;115:829–35.PubMedCrossRef
50.
go back to reference Nguyen MH, Bryant K, O’Neill SG. Vitamin D in SLE: a role in pathogenesis and fatigue? A review of the literature. Lupus. 2018;27:2003–11.PubMedCrossRef Nguyen MH, Bryant K, O’Neill SG. Vitamin D in SLE: a role in pathogenesis and fatigue? A review of the literature. Lupus. 2018;27:2003–11.PubMedCrossRef
51.
go back to reference Liu Y, Wen H. Impact of vitamin D deficiency on clinical parameters in treatment-naïve rheumatoid arthritis patients. Z Rheumatol. 2018;77:833–40.PubMedCrossRef Liu Y, Wen H. Impact of vitamin D deficiency on clinical parameters in treatment-naïve rheumatoid arthritis patients. Z Rheumatol. 2018;77:833–40.PubMedCrossRef
52.
go back to reference Chahardoli R, Saboor-Yaraghi A-A, Amouzegar A, Khalili D, Vakili AZ, Azizi F. Can supplementation with vitamin D modify thyroid autoantibodies (Anti-TPO Ab, Anti-Tg Ab) and thyroid profile (T3, T4, TSH) in hashimoto’s thyroiditis? A double blind, randomized clinical trial. Horm Metab Res Horm Stoffwechselforschung Horm Metab. 2019;51:296–301.CrossRef Chahardoli R, Saboor-Yaraghi A-A, Amouzegar A, Khalili D, Vakili AZ, Azizi F. Can supplementation with vitamin D modify thyroid autoantibodies (Anti-TPO Ab, Anti-Tg Ab) and thyroid profile (T3, T4, TSH) in hashimoto’s thyroiditis? A double blind, randomized clinical trial. Horm Metab Res Horm Stoffwechselforschung Horm Metab. 2019;51:296–301.CrossRef
53.
54.
go back to reference Byrne R, Todd I, Tighe PJ, Fairclough LC. Autoantibodies in chronic obstructive pulmonary disease: a systematic review. Immunol Lett. 2019;214:8–15.PubMedCrossRef Byrne R, Todd I, Tighe PJ, Fairclough LC. Autoantibodies in chronic obstructive pulmonary disease: a systematic review. Immunol Lett. 2019;214:8–15.PubMedCrossRef
Metadata
Title
Effects of repeated infections with non-typeable Haemophilus influenzae on lung in vitamin D deficient and smoking mice
Authors
Jef Serré
Ajime Tom Tanjeko
Carolien Mathyssen
Tobias Heigl
Annelore Sacreas
Dana Paulina Cook
Erik Verbeken
Karen Maes
Jan Verhaegen
Charles Pilette
Jeroen Vanoirbeek
Conny Gysemans
Chantal Mathieu
Bart Vanaudenaerde
Wim Janssens
Ghislaine Gayan-Ramirez
Publication date
01-12-2022
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2022
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/s12931-022-01962-6

Other articles of this Issue 1/2022

Respiratory Research 1/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.